146 related articles for article (PubMed ID: 21126022)
1. Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase.
Ferrari S; Morandi F; Motiejunas D; Nerini E; Henrich S; Luciani R; Venturelli A; Lazzari S; Calò S; Gupta S; Hannaert V; Michels PA; Wade RC; Costi MP
J Med Chem; 2011 Jan; 54(1):211-21. PubMed ID: 21126022
[TBL] [Abstract][Full Text] [Related]
2. Structure-based selectivity optimization of piperidine-pteridine derivatives as potent Leishmania pteridine reductase inhibitors.
Corona P; Gibellini F; Cavalli A; Saxena P; Carta A; Loriga M; Luciani R; Paglietti G; Guerrieri D; Nerini E; Gupta S; Hannaert V; Michels PA; Ferrari S; Costi PM
J Med Chem; 2012 Oct; 55(19):8318-29. PubMed ID: 22946585
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
Hardy LW; Matthews W; Nare B; Beverley SM
Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
Cavazzuti A; Paglietti G; Hunter WN; Gamarro F; Piras S; Loriga M; Allecca S; Corona P; McLuskey K; Tulloch L; Gibellini F; Ferrari S; Costi MP
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1448-53. PubMed ID: 18245389
[TBL] [Abstract][Full Text] [Related]
5. Biochemical effects of riluzole on Leishmania parasites.
Guerrieri D; Ferrari S; Costi MP; Michels PA
Exp Parasitol; 2013 Mar; 133(3):250-4. PubMed ID: 23206955
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and Genetic Tests for Inhibitors of Leishmania Pteridine Pathways.
Hardy LW; Matthews W; Nare B; Beverley SM
Exp Parasitol; 1997 Nov; 87(3):158-70. PubMed ID: 9398595
[TBL] [Abstract][Full Text] [Related]
7. Identification of Novel Potential Inhibitors of Pteridine Reductase 1 in
Kimuda MP; Laming D; Hoppe HC; Tastan Bishop Ö
Molecules; 2019 Jan; 24(1):. PubMed ID: 30609681
[TBL] [Abstract][Full Text] [Related]
8. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity.
Nare B; Luba J; Hardy LW; Beverley S
Parasitology; 1997; 114 Suppl():S101-10. PubMed ID: 9309772
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
Tulloch LB; Martini VP; Iulek J; Huggan JK; Lee JH; Gibson CL; Smith TK; Suckling CJ; Hunter WN
J Med Chem; 2010 Jan; 53(1):221-9. PubMed ID: 19916554
[TBL] [Abstract][Full Text] [Related]
10. Leishmania donovani pteridine reductase 1: biochemical properties and structure-modeling studies.
Kumar P; Kumar A; Verma SS; Dwivedi N; Singh N; Siddiqi MI; Tripathi RP; Dube A; Singh N
Exp Parasitol; 2008 Sep; 120(1):73-9. PubMed ID: 18617167
[TBL] [Abstract][Full Text] [Related]
11. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
Fogel GB; Cheung M; Pittman E; Hecht D
J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
[TBL] [Abstract][Full Text] [Related]
12. Sesquiterpene Lactones with Dual Inhibitory Activity against the
Possart K; Herrmann FC; Jose J; Costi MP; Schmidt TJ
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011381
[TBL] [Abstract][Full Text] [Related]
13. Structural Insights into the Development of Cycloguanil Derivatives as
Landi G; Linciano P; Borsari C; Bertolacini CP; Moraes CB; Cordeiro-da-Silva A; Gul S; Witt G; Kuzikov M; Costi MP; Pozzi C; Mangani S
ACS Infect Dis; 2019 Jul; 5(7):1105-1114. PubMed ID: 31012301
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design and synthesis of antiparasitic pyrrolopyrimidines targeting pteridine reductase 1.
Khalaf AI; Huggan JK; Suckling CJ; Gibson CL; Stewart K; Giordani F; Barrett MP; Wong PE; Barrack KL; Hunter WN
J Med Chem; 2014 Aug; 57(15):6479-94. PubMed ID: 25007262
[TBL] [Abstract][Full Text] [Related]
15. High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor.
Landi G; Linciano P; Tassone G; Costi MP; Mangani S; Pozzi C
Acta Crystallogr D Struct Biol; 2020 Jun; 76(Pt 6):558-564. PubMed ID: 32496217
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of dihydrofolate reductase in Leishmania and trypanosomes.
Gilbert IH
Biochim Biophys Acta; 2002 Jul; 1587(2-3):249-57. PubMed ID: 12084467
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database.
Desai PV; Patny A; Sabnis Y; Tekwani B; Gut J; Rosenthal P; Srivastava A; Avery M
J Med Chem; 2004 Dec; 47(26):6609-15. PubMed ID: 15588096
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
Kaur J; Sundar S; Singh N
J Antimicrob Chemother; 2010 Aug; 65(8):1742-8. PubMed ID: 20519355
[TBL] [Abstract][Full Text] [Related]
19. Targeting pteridine reductase 1 and dihydrofolate reductase: the old is a new trend for leishmaniasis drug discovery.
das Neves GM; Kagami LP; Gonçalves IL; Eifler-Lima VL
Future Med Chem; 2019 Aug; 11(16):2107-2130. PubMed ID: 31370699
[TBL] [Abstract][Full Text] [Related]
20. Leishmania major pteridine reductase 1 belongs to the short chain dehydrogenase family: stereochemical and kinetic evidence.
Luba J; Nare B; Liang PH; Anderson KS; Beverley SM; Hardy LW
Biochemistry; 1998 Mar; 37(12):4093-104. PubMed ID: 9521731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
